For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

John L. McGoldrick

Executive Vice President and General Counsel, Bristol-Myers Squibb Company

John McGoldrick is executive vice president and general counsel of Bristol-Myers Squibb Company, a diversified worldwide health care company, whose principal businesses are pharmaceuticals, medical devices, consumer medicines and nutritionals. He is vice chairman of the Company’s Executive Committee. Mr. McGoldrick also has overall responsibility for Global Corporate Policy. He is a director of the Bristol-Myers Squibb Foundation.

In addition to his responsibility for the legal and policy functions, Mr. McGoldrick has responsibility for Government Affairs, Corporate Security, and Philanthropy. He is a member of Bristol-Myers Squibb’s Pension and Savings Committee. Previously, Mr. McGoldrick was president of the Company’s Medical Devices Group responsible for the company’s orthopedics, wound care, and ostomy businesses. He is a trustee of the Healthcare Institute of New Jersey, and was formerly a board member of AdvaMed, the medical device trade association.

Mr. McGoldrick has responsibility for Bristol-Myers Squibb’s HIV/AIDS initiatives in Africa, including its groundbreaking $150 million Secure The Future programs in sub-Saharan Africa, as well as the ACCESS program to make antiretroviral therapy more accessible in the developing world. He is a principal of, and has chaired, the Accelerating Access Initiative (AAI), the global consortium of five U.N.-led international agencies and eight pharmaceutical companies; AAI’s mission is to increase access to HIV medicines.

He served as a director of the New Jersey Transit Corporation, the U.S.'s largest statewide transportation system, from its founding in 1979 until 2005, including service as vice chair. He is also a Director of Zimmer Holdings, Inc., the world’s leading manufacturer of artificial hips and knees and other orthopedic products. He chairs the Committee on Directors and Corporate Governance of the Zimmer Board, and previously chaired the Compensation and Management Development Committee.

Mr. McGoldrick was earlier a trial and appellate lawyer and partner of the law firm of McCarter & English, where he sat on its Executive Committee. He is an elected member of the American Law Institute, a fellow of the American College of Trial Lawyers, a fellow of the American Academy of Appellate Lawyers, and a fellow of the American Bar Association. He is also a member of The Association of General Counsel, the Council of Chief Legal Officers, and the Executive Committee of the CPR Institute for Dispute Resolution.

He is a member of The Aspen Institute on the World Economy, of the Council on Foreign Relations, of the Council for the U.S. and Italy, and of the World Economic Forum (Davos). He is also a director of the Regional Plan Association, a trustee of Legal Services of New Jersey, a trustee of The Foundation for New Jersey Public Broadcasting, a trustee of Montclair State University, a member of The Committee to Visit the College and The Committee to Visit the School of Public Health of the Harvard Board of Overseers, and a member of the Harvard School of Public Health Leadership Council, and the Harvard Malaria Initiative Advisory Council.

He is a graduate of Harvard College and the Harvard Law School.